ATE118484T1 - Substituierte 3-amino-2,3,4,5-tetrahydro-1- aryloxy-3-benzazepine, verfahren zu ihrer herstellung und ihre verwendung als modulatoren der neurotransmitterfunktion. - Google Patents

Substituierte 3-amino-2,3,4,5-tetrahydro-1- aryloxy-3-benzazepine, verfahren zu ihrer herstellung und ihre verwendung als modulatoren der neurotransmitterfunktion.

Info

Publication number
ATE118484T1
ATE118484T1 AT92116111T AT92116111T ATE118484T1 AT E118484 T1 ATE118484 T1 AT E118484T1 AT 92116111 T AT92116111 T AT 92116111T AT 92116111 T AT92116111 T AT 92116111T AT E118484 T1 ATE118484 T1 AT E118484T1
Authority
AT
Austria
Prior art keywords
modulators
hydrogen
benzazepines
tetrahydro
aryloxy
Prior art date
Application number
AT92116111T
Other languages
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of ATE118484T1 publication Critical patent/ATE118484T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT92116111T 1991-09-23 1992-09-21 Substituierte 3-amino-2,3,4,5-tetrahydro-1- aryloxy-3-benzazepine, verfahren zu ihrer herstellung und ihre verwendung als modulatoren der neurotransmitterfunktion. ATE118484T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/763,711 US5202319A (en) 1991-09-23 1991-09-23 Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines

Publications (1)

Publication Number Publication Date
ATE118484T1 true ATE118484T1 (de) 1995-03-15

Family

ID=25068602

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92116111T ATE118484T1 (de) 1991-09-23 1992-09-21 Substituierte 3-amino-2,3,4,5-tetrahydro-1- aryloxy-3-benzazepine, verfahren zu ihrer herstellung und ihre verwendung als modulatoren der neurotransmitterfunktion.

Country Status (8)

Country Link
US (1) US5202319A (de)
EP (1) EP0534344B1 (de)
JP (1) JP2665434B2 (de)
AT (1) ATE118484T1 (de)
DE (1) DE69201424T2 (de)
DK (1) DK0534344T3 (de)
ES (1) ES2068662T3 (de)
GR (1) GR3015494T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100710547B1 (ko) * 2002-01-02 2007-04-24 에스케이 주식회사 (s)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1H-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
KR100710548B1 (ko) * 2002-12-26 2007-04-24 에스케이 주식회사 (s)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1H-1-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
KR20100017767A (ko) 2007-05-10 2010-02-16 에이엠알 테크놀로지, 인크. 아릴옥시- 및 헤테로 아릴옥시-치환된 테트라히드로벤즈아제핀 및 도파민 및 세로토닌의 재흡수를 차단하기 위한 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4988690A (en) * 1982-06-14 1991-01-29 Hoechst-Roussel Pharmaceuticals Inc. 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
US4794181A (en) * 1982-06-14 1988-12-27 Hoechst-Roussel Pharmaceuticals, Inc. 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines
DK0415103T3 (da) * 1989-08-02 1995-06-19 Hoechst Roussel Pharma 2,3-Dihydro-1-(pyridinylamino)-indoler, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Also Published As

Publication number Publication date
DE69201424D1 (de) 1995-03-23
DK0534344T3 (da) 1995-07-17
US5202319A (en) 1993-04-13
JPH05301859A (ja) 1993-11-16
ES2068662T3 (es) 1995-04-16
EP0534344B1 (de) 1995-02-15
GR3015494T3 (en) 1995-06-30
JP2665434B2 (ja) 1997-10-22
DE69201424T2 (de) 1995-07-13
EP0534344A1 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
NO902862D0 (no) Heteroarylamino- og heteroaryloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav.
DE69635079D1 (de) Verwendung von il-11 zur behandlung von entzündung
ATE161840T1 (de) Substituierte 3-(pyridinylamino)-indole und benzo(b>thiophene, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE168689T1 (de) Substituierte (pyridinylamino)-benzisoxazole und -benzisothiazole, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE166355T1 (de) Substituierte aminothienopyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE176231T1 (de) Triazin-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE69201424D1 (de) Substituierte 3-Amino-2,3,4,5-Tetrahydro-1-Aryloxy-3-Benzazepine, Verfahren zu ihrer Herstellung und ihre Verwendung als Modulatoren der Neurotransmitterfunktion.
DE69019920D1 (de) Benzocycloalkylaminopyridinamine und verwandte Verbindungen, Verfahren zu ihrer Herstellung, Zwischenverbindungen und ihre Verwendung als Arzneimittel.
IL147575A0 (en) Method for purifying keratinocyte growth factors
DE68902386D1 (de) N-pyridinyl-9h-carbazol-9-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
FI98366B (fi) Menetelmä karbonyylin sisältävän akridiinin pelkistämiseksi
ATE122047T1 (de) 4,5,5a,6-tetrahydro-3h-isoxyzolo(5,4,3- k1)acridinderivate, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente.
ATE183746T1 (de) Pyrido(3,4-b>pyrrolo(1,2-e>(1,4,5>oxadiazepine und verwandte analoge, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE135682T1 (de) 2-(3-phenylpropyl)hydrazine, verfahren zu ihrer herstellung, zwischenprodukte dafür und ihre verwendung als medikamente

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee